Nifty, Sensex remains under pressure from global factors – Wednesday closing report
Moneylife Digital Team
0
We had mentioned in Tuesday’s closing report that Nifty, Sensex may move sideways. On Wednesday, the indices opened higher but ended in the red with minor losses. On the NSE, there were 887 advances, 1,088 declines and 61 unchanged.
The trends of the major indices in the course of Wednesday’s trading are given in the table below:
Cadila Healthcare has informed the exchanges that a consortium of investors Multiples Alternate Asset Management, Canada Pension Plan Investment Board (CPPIB) and Rakesh Jhunjhunwala-backed Rare Enterprises will buy its animal healthcare business for Rs 2,921 crore.
Nifty, Sensex may rally on global cues – Weekly closing report
Moneylife Digital Team
0
We had mentioned in previous week’s closing report that Nifty, Sensex may move sideways. The major indices opened higher but headed downward and ended with minor losses over previous Friday’s closing price. The trend of the major indices in the week is given in the table:
On Monday, the indices opened higher and made decent gains. On the NSE, there were 1,349 advances, 641 declines and 89 unchanged.
Jindal Steel & Power made prepayment of Rs 2,462 crore to its term lenders as a strategy to reduce debt and build a robust balance sheet.
Company Update - Cadila Healthcare - ICICI Direct equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Go
Your browser has Javascript disabled, so some things may not quite work how they should on LI right now: please enable JavaScript in your browser to fix things, we have no nefarious trackers, or scripts by Facebook, Google or others.
In Brief
Thursday, 13 May 2021 18:17 Private equity / VC
Zydus Animal Health and Investments Limited (ZAHL) a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other ancillary agreements to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.
For lump sum consideration of Rs 2921 croreZydus Animal Health and Investments (ZAHL) a wholly owned material subsidiary of Cadila Healthcare, has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (Definitive Agreements) to sell and transfer its Animal Healthcare Established Markets Undertaking (Undertaking or Zydus AH) to Multiples Alternate Asset Management (Multiples) led consortium.
Zydus AH is the animal health business of ZAHL focused on India and certain other countries. The consortium, including Canada Pension Plan Investment Board (CPP Investments) and RARE Enterprises (RARE), has agreed to purchase the Undertaking through an SPV controlled by them, in the name of Zenex Animal Health India.